Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A cross-sectional survey of clinical practice and implementation challenges with no quantitative comparison group, efficacy data, or primary outcome measure; descriptive in nature and identifying barriers rather than testing an intervention or confirming an effect.
A cross-sectional study using advanced imaging (HR-pQCT) to detect bone health impairment missed by standard DXA in pediatric ALL survivors; real findings in a limited sample that warrant confirmation in larger, prospective cohorts.
A bibliometric analysis of publication trends and research hotspots in therapeutic drug monitoring for leukemia; describes the research landscape rather than testing a clinical hypothesis or reporting primary outcome data.
Retrospective cohort study confirming that younger age predicts better melanoma survival; well-designed with adequate sample and long follow-up, but uses observational data and a single centre, limiting practice-changing impact.
A narrative review synthesizing molecular mechanisms and epidemiologic evidence across multiple pollutants and hematologic malignancies, without presenting new primary data or a quantitative meta-analysis, raising questions about causation rather than definitively answering them.
A single-centre cross-sectional study identifying modifiable and non-modifiable factors associated with HRQoL in paediatric leukaemia using validated instruments and multivariable regression, with moderate sample size and substantial explained variance, but lacking a comparator or control group.
A large descriptive epidemiological analysis confirming known patterns of childhood leukemia burden globally, with stratified trend data reinforcing established disparities between high- and low-resource settings, but not providing clinical intervention evidence.
Single-centre cross-sectional study with modest sample size describing frequencies of endocrine complications in ALL survivors; provides descriptive data but lacks a comparator group and cannot establish causation or generalizability.